Area of research
Pulmonary and Respiratory Medicine · Infectious Diseases
Research interest
Research focused on COPD and Coronavirus disease 2019 (COVID-19), with related work in Oxidative stress, Exacerbation, Moxifloxacin. Notable publications include 'Critical care crisis and some recommendations during the COVID-19 epidemic in China', 'Oxidative stress alters global histone modification and DNA methylation', and 'Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study'.
A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. levofloxacin for community-acquired pneumonia in adult patients
[A prospective multi-center clinical investigation of HIV-negative pulmonary cryptococcosis in China].
A randomized, controlled, multicenter clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus moxifloxacin in adult patients with community-acquired pneumonia
Critical care crisis and some recommendations during the COVID-19 epidemic in China
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study
Effectiveness of inspiratory plus expiratory neuromuscular electrical stimulation in the rehabilitation of patients with severe COPD
Inspiratory Plus Expiratory Neuromuscular Electrical Stimulation Versus Diaphragm Pacing for Rehabilitation in Severe COPD Patients: A Randomized Controlled Trial
Associations between daily air quality and hospitalisations for acute exacerbation of chronic obstructive pulmonary disease in Beijing, 2013–17: an ecological analysis
Oxidative stress alters global histone modification and DNA methylation